With available cell lines against each genomic dataset, the Precision Medicine Lab is set to take its genetic analyses and statistical predictions back into the lab for functional validation and drug screening. This will create a comprehensive pipeline that combines the power of big data and machine learning with experimental screening platforms for further research in conjunction with interested partners from around the world. The Lab is also interested in in vivo drug screening methods using model organisms such as fruit flies and diagnostic methods based on microfluidics and MEMS, both of which are currently under development. This puts us at the forefront of translational research in the country and unlocks new opportunities for the biomedical community in Phase-V and the rest of Pakistan.